ROSSARINSERossari Biotech LimitedMediumNeutral
Announced Thu, 21 May · 21:23 IST

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015.

Strategic Transactions View source PDF

ROSSARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.1%1-day move
₹522.00
prior close
₹520.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.1-0.4-0.6+3.1+3.5+2.9+0.2-0.4+0.7-1.9+5.6-4.8
Up moveDown movePending
AI summary

Rossari Biotech's material subsidiary Unitop Chemicals Private Limited has completed the sale of its office premises located at Saki Naka, Mumbai. The transaction was completed on May 21, 2026, for a total consideration of Rs. 10.50 crore including stamp duty. The buyers are Mr. Jitendra Hakaram Choudhary, Mrs. Sunita Jitendra Choudhary, and Mr. Bhrupal Jitendra Choudhary, who are not related to the promoter or promoter group. The transaction is not classified as a related party transaction and was conducted at arm's length.

Likely market impact

The sale provides Rs. 10.50 crore in cash to the company from asset monetization. This is a one-time non-recurring gain and does not affect the core biotech operations. Shareholders may view this positively as it strengthens the balance sheet, though it does not change the fundamental business outlook.